Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,352 public trials 1,986 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

NCT03255577

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • BAPTIST ALLIANCE - MCI (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only and Follow Up) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of INCB123667 in Subjects With Advanced Solid Tumors

NCT05238922

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Rocky Mountain Cancer Centers-Sky Ridge Lone Tree, Colorado, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

NCT03414658

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details

Related conditions